FcγRIIb expression on B cells is associated with treatment efficacy for acute rejection after kidney transplantation

Molecular Immunology

Volumn 85, Issue , 2017, Pages 283-292

  Jin, Juan ^a,b   Gong, Jianguang ^a,b   Lin, Bo ^a,b   Li, Yiwen ^a,b   He, Qiang ^a,b  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b PEOPLE S HOSPITAL OF HANGZHOU MEDICAL COLLEGE   (China)

Author keywords

Acute rejection; CD28; Fc receptors; Immunoglobulin G; Renal transplantation

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FC RECEPTOR IIB; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; FC RECEPTOR; FCGR2B PROTEIN, RAT; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SPLEEN CELL; SPLENIC B CELL; THERAPY EFFECT; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FISCHER 344 RAT; GRAFT REJECTION; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE ACTIVATION; RANDOMIZATION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECEPTORS, IGG;

EID: 85016165949     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2017.03.006     Document Type: Article

References (47)

1. Andreoni, K.A., Forbes, R., Andreoni, R.M., Phillips, G., Stewart, H., Ferris, M., Age-related kidney transplant outcomes: health disparities amplified in adolescence. JAMA Intern. Med. 173 (2013), 1524–1532.
2. Anthony, R.M., Nimmerjahn, F., Ashline, D.J., Reinhold, V.N., Paulson, J.C., Ravetch, J.V., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320 (2008), 373–376.
3. Arnold, M.L., Fuernrohr, B.G., Weiss, K.M., Harre, U., Wiesener, M.S., Spriewald, B.M., Association of a coding polymorphism in Fc gamma receptor 2A and graft survival in re-transplant candidates. Hum. Immunol. 76 (2015), 759–764.
4. Azuma, H., Isaka, Y., Li, X., Hunig, T., Sakamoto, T., Nohmi, H., Takabatake, Y., Mizui, M., Kitazawa, Y., Ichimaru, N., Ibuki, N., Ubai, T., Inamoto, T., Katsuoka, Y., Takahara, S., Superagonistic CD28 antibody induces donor-specific tolerance in rat renal allografts. Am. J. Transplant. 8 (2008), 2004–2014.
5. Bezie, S., Picarda, E., Tesson, L., Renaudin, K., Durand, J., Menoret, S., Merieau, E., Chiffoleau, E., Guillonneau, C., Caron, L., Anegon, I., Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells. PLoS One, 10, 2015, e0119686.
6. Blair, P.A., Norena, L.Y., Flores-Borja, F., Rawlings, D.J., Isenberg, D.A., Ehrenstein, M.R., Mauri, C., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32 (2010), 129–140.
7. Bruhns, P., Samuelsson, A., Pollard, J.W., Ravetch, J.V., Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18 (2003), 573–581.
8. Callaghan, C.J., Win, T.S., Motallebzadeh, R., Conlon, T.M., Chhabra, M., Harper, I., Sivaganesh, S., Bolton, E.M., Bradley, J.A., Brownlie, R.J., Smith, K.G., Pettigrew, G.J., Regulation of allograft survival by inhibitory FcgammaRIIb signaling. J. Immunol. 189 (2012), 5694–5702.
9. Cherukuri, A., Rothstein, D.M., Clark, B., Carter, C.R., Davison, A., Hernandez-Fuentes, M., Hewitt, E., Salama, A.D., Baker, R.J., Immunologic human renal allograft injury associates with an altered IL-10/TNF-alpha expression ratio in regulatory B cells. J. Am. Soc. Nephrol. 25 (2014), 1575–1585.
10. Chronic Kidney Disease Prognosis, Prognosis, C., Matsushita, K., van der Velde, M., Astor, B.C., Woodward, M., Levey, A.S., de Jong, P.E., Coresh, J., Gansevoort, R.T., Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375 (2010), 2073–2081.
11. Clatworthy, M.R., Targeting B cells and antibody in transplantation. Am. J. Transplant. 11 (2011), 1359–1367.
12. Djamali, A., Kaufman, D.B., Ellis, T.M., Zhong, W., Matas, A., Samaniego, M., Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am. J. Transplant. 14 (2014), 255–271.
13. Farkas, D., Alhussaini, A.A., Kraskauskas, D., Kraskauskiene, V., Cool, C.D., Nicolls, M.R., Natarajan, R., Farkas, L., Nuclear factor kappaB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats. Am. J. Respir. Cell Mol. Biol. 51 (2014), 413–425.
14. Flesch, B.K., Bauer, F., Neppert, J., Rapid typing of the human Fc gamma receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion 38 (1998), 174–176.
15. Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E., Hsu, C.Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351 (2004), 1296–1305.
16. Gotti, E., Perico, N., Perna, A., Gaspari, F., Cattaneo, D., Caruso, R., Ferrari, S., Stucchi, N., Marchetti, G., Abbate, M., Remuzzi, G., Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings. J. Am. Soc. Nephrol. 14 (2003), 755–766.
17. Grams, M.E., Chow, E.K., Segev, D.L., Coresh, J., Lifetime incidence of CKD stages 3–5 in the United States. Am. J. Kidney Dis. 62 (2013), 245–252.
18. Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., Lambrecht, B.N., The function of Fcgamma receptors in dendritic cells and macrophages. Nat. Rev. Immunol. 14 (2014), 94–108.
19. Hamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., Tedder, T.F., Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med. 203 (2006), 743–753.
20. Haspot, F., Seveno, C., Dugast, A.S., Coulon, F., Renaudin, K., Usal, C., Hill, M., Anegon, I., Heslan, M., Josien, R., Brouard, S., Soulillou, J.P., Vanhove, B., Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am. J. Transplant. 5 (2005), 2339–2348.
21. Ingulli, E., Mechanism of cellular rejection in transplantation. Pediatr. Nephrol. 25 (2010), 61–74.
22. Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D.J., Yanaba, K., Venturi, G.M., Szabolcs, P.M., Bernstein, S.H., Magro, C.M., Williams, A.D., Hall, R.P., St Clair, E.W., Tedder, T.F., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117 (2011), 530–541.
23. Jordan, S.C., Vo, A., Tyan, D., Toyota, M., Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. Trans. Am. Clin. Climatol. Assoc. 117 (2006), 199–211 (discussion 211).
24. Kaneko, Y., Nimmerjahn, F., Madaio, M.P., Ravetch, J.V., Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 203 (2006), 789–797.
25. Kaneko, Y., Nimmerjahn, F., Ravetch, J.V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313 (2006), 670–673.
26. Kiss, E., Popovic, Z., Bedke, J., Wang, S., Bonrouhi, M., Gretz, N., Stettner, P., Teupser, D., Thiery, J., Porubsky, S., Adams, J., Grone, H.J., Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRalpha. Am. J. Pathol. 179 (2011), 92–103.
27. Knoll, G., Cockfield, S., Blydt-Hansen, T., Baran, D., Kiberd, B., Landsberg, D., Rush, D., Cole, E., Kidney Transplant Working Group of the Canadian Society of, T, Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 173 (2005), 1181–1184.
28. Kulinski, J.M., Leonardo, S.M., Mounce, B.C., Malherbe, L., Gauld, S.B., Tarakanova, V.L., Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection. J. Virol. 86 (2012), 12826–12837.
29. Lux, A., Aschermann, S., Biburger, M., Nimmerjahn, F., The pro and anti-inflammatory activities of immunoglobulin G. Ann. Rheum. Dis. 69:Suppl. 1 (2010), i92–96.
30. Nayak, B.N., Friel, J.K., Rempel, C.B., Jones, P.J., Energy-restricted diets result in higher numbers of CD4+, CD8+, immunoglobulins (A, M, and G) and CD45RA cells in spleen and CD4+, immunoglobulin A, and CD45RA cells in colonic lamina propria of rats. Nutr. Res. 29 (2009), 487–493.
31. Nimmerjahn, F., Ravetch, J.V., Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310 (2005), 1510–1512.
32. Nimmerjahn, F., Ravetch, J.V., The antiinflammatory activity of IgG: the intravenous IgG paradox. J. Exp. Med. 204 (2007), 11–15.
33. Nimmerjahn, F., Ravetch, J.V., Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8 (2008), 34–47.
34. Ponticelli, C., The mechanisms of acute transplant rejection revisited. J. Nephrol. 25 (2012), 150–158.
35. Puttarajappa, C., Shapiro, R., Tan, H.P., Antibody-mediated rejection in kidney transplantation: a review. J. Transplant., 2012, 2012, 193724.
36. Ray, A., Mann, M.K., Basu, S., Dittel, B.N., A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 230 (2011), 1–9.
37. Samuelsson, A., Towers, T.L., Ravetch, J.V., Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291 (2001), 484–486.
38. Smith, K.G., Clatworthy, M.R., FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 10 (2010), 328–343.
39. Suthanthiran, M., Acute rejection of renal allografts: mechanistic insights and therapeutic options. Kidney Int. 51 (1997), 1289–1304.
40. White, A.L., Chan, H.T., French, R.R., Willoughby, J., Mockridge, C.I., Roghanian, A., Penfold, C.A., Booth, S.G., Dodhy, A., Polak, M.E., Potter, E.A., Ardern-Jones, M.R., Verbeek, J.S., Johnson, P.W., Al-Shamkhani, A., Cragg, M.S., Beers, S.A., Glennie, M.J., Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies. Cancer Cell 27 (2015), 138–148.
41. Xiong, L., Yang, L., Effects of alkaloid sinomenine on levels of IFN-gamma, IL-1beta, TNF-alpha and IL-6 in a rat renal allograft model. Immunotherapy 4 (2012), 785–791.
42. Yoshikawa, T., Takeuchi, H., Suda, K., Miyasho, T., Yamada, S., Okamoto, M., Kawamura, Y., Maruyama, I., Kitajima, M., Kitagawa, Y., High-dose immunoglobulin preparations improve survival in a CLP-induced rat model of sepsis. Langenbecks Arch. Surg. 397 (2012), 457–465.
43. Yuan, F.F., Watson, N., Sullivan, J.S., Biffin, S., Moses, J., Geczy, A.F., Chapman, J.R., Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection. Transplantation 78 (2004), 766–769.
44. Zakrzewicz, D., Zakrzewicz, A., Wilker, S., Boedeker, R.H., Padberg, W., Eickelberg, O., Grau, V., Dimethylarginine metabolism during acute and chronic rejection of rat renal allografts. Nephrol. Dial. Transplant. 26 (2011), 124–135.
45. Zhang, T., Fresnay, S., Welty, E., Sangrampurkar, N., Rybak, E., Zhou, H., Cheng, X.F., Feng, Q., Avon, C., Laaris, A., Whitters, M., Nagelin, A.M., O'Hara, R.M. Jr., Azimzadeh, A.M., Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am. J. Transplant. 11 (2011), 1599–1609.
46. Zhang, L., Wang, F., Wang, L., Wang, W., Liu, B., Liu, J., Chen, M., He, Q., Liao, Y., Yu, X., Chen, N., Zhang, J.E., Hu, Z., Liu, F., Hong, D., Ma, L., Liu, H., Zhou, X., Chen, J., Pan, L., Chen, W., Wang, W., Li, X., Wang, H., Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379 (2012), 815–822.
47. Zhao, H., Luo, X., Zhou, Z., Liu, J., Tralau-Stewart, C., George, A.J., Ma, D., Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats. Kidney Int. 85 (2014), 112–123.